(Q45002840)

8 December 2017

title

Association of Pro12Ala (rs1801282) variant of PPAR gamma with rheumatoid arthritis in a Pakistani population (English)

1 reference

8 December 2017

1 reference

1 reference

Syed Fazal Jalil

1

1 reference

8 December 2017

Iltaf Ahmed

2

1 reference

8 December 2017

Zeeshan Gauhar

3

1 reference

8 December 2017

Mushtaq Ahmed

4

1 reference

8 December 2017

Javaid M Malik

5

1 reference

8 December 2017

Peter John

6

1 reference

8 December 2017

Attya Bhatti

7

1 reference

8 December 2017

language of work or name

1 reference

30 April 2013

1 reference

Rheumatology International

8 December 2017

published in

1 reference

8 December 2017

volume

34

1 reference

8 December 2017

issue

5

1 reference

8 December 2017

page(s)

699-703

1 reference

https://scigraph.springernature.com/pub.10.1007/s00296-013-2768-2

8 December 2017

exact match

0 references

cites work

The genetics revolution and the assault on rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

Evolving concepts of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

Roles of PPARs in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

Controversy: PPARgamma as a target for treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

The pleiotropic functions of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma-2 gene (PPARγ2) is associated with increased risk of coronary artery disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

Association of the PPARgamma gene polymorphism Pro12Ala with delayed onset of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

Catalase and PPARgamma2 genotype and risk of rheumatoid arthritis in Koreans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

Genetic Variation in PPARG Encoding Peroxisome Proliferator-Activated Receptor γ Associated With Carotid Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2768-2

Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome

21 January 2018

1 reference

12 December 2020

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

1 reference

12 December 2020

[Association of the Pro12Ala polymorphism in peroxisome proliferators activated receptor-gamma gene with rheumatoid arthritis in Sichuan Province of China].

1 reference

12 December 2020

The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance

1 reference

12 December 2020

10.1007/S00296-013-2768-2

Identifiers

DOI

1 reference

Dimensions Publication ID

8 December 2017

1023347570

0 references

1 reference